WO2002069956A3 - Use of carnitine for increasing testosteron - Google Patents

Use of carnitine for increasing testosteron Download PDF

Info

Publication number
WO2002069956A3
WO2002069956A3 PCT/EP2002/000464 EP0200464W WO02069956A3 WO 2002069956 A3 WO2002069956 A3 WO 2002069956A3 EP 0200464 W EP0200464 W EP 0200464W WO 02069956 A3 WO02069956 A3 WO 02069956A3
Authority
WO
WIPO (PCT)
Prior art keywords
carnitine
increasing
testosteron
testosterone
alkanoyl
Prior art date
Application number
PCT/EP2002/000464
Other languages
French (fr)
Other versions
WO2002069956A2 (en
Inventor
Andrea Schaffhauser
Paula Gaynor
Original Assignee
Lonza Ag
Andrea Schaffhauser
Paula Gaynor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lonza Ag, Andrea Schaffhauser, Paula Gaynor filed Critical Lonza Ag
Publication of WO2002069956A2 publication Critical patent/WO2002069956A2/en
Publication of WO2002069956A3 publication Critical patent/WO2002069956A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

Use of carnitine or alkanoyl-carnitine administration to a human for increasing serum levels of testosterone.
PCT/EP2002/000464 2001-01-22 2002-01-18 Use of carnitine for increasing testosteron WO2002069956A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01101355 2001-01-22
EP01101355.4 2001-01-22

Publications (2)

Publication Number Publication Date
WO2002069956A2 WO2002069956A2 (en) 2002-09-12
WO2002069956A3 true WO2002069956A3 (en) 2002-11-07

Family

ID=8176267

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2002/000464 WO2002069956A2 (en) 2001-01-22 2002-01-18 Use of carnitine for increasing testosteron

Country Status (1)

Country Link
WO (1) WO2002069956A2 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5817329A (en) * 1997-02-28 1998-10-06 Gardiner; Paul T. Nutritional supplement for increased muscle size and strength for body builders

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5817329A (en) * 1997-02-28 1998-10-06 Gardiner; Paul T. Nutritional supplement for increased muscle size and strength for body builders

Also Published As

Publication number Publication date
WO2002069956A2 (en) 2002-09-12

Similar Documents

Publication Publication Date Title
AU2002258063A1 (en) Medicament applicator
AU2180400A (en) A pharmaceutical combination for the treatment of depression
AU2002220268A1 (en) Anti-drawback medical valve
EP1186293A3 (en) Intermittent administration of a growth hormone secretagogue
AU2002303502A1 (en) Improved leads for the treatment of patients with chf
AU2002253039A1 (en) Tramadol-based medicament
AU2002357086A1 (en) Healing abutment
AUPR773901A0 (en) Fracture cuff
AU2002210385A1 (en) Furazanyl-triazole derivates for the treatment of diseases
AU2001233208A1 (en) Human sulfatases
AU2003258145A1 (en) Substituted phenylindoles for the treatment of hiv
AU5491701A (en) Lingual arch developer
AU2001243515A1 (en) Combination drug therapy
AU2002310684A1 (en) Vitamin D analogues
AUPR906101A0 (en) Liquid developers
AU2002353659A1 (en) Simvastatin dosage forms
AU2002335667A1 (en) Modified reoviral therapy
WO2002069956A3 (en) Use of carnitine for increasing testosteron
AU2002235202A1 (en) Treatment of bone disorders by modulation of fgfr3
AU2001262520A1 (en) Combined preparation for the treatment of neoplasic diseases
AU2001283957A1 (en) Treatment of ocular disorders with somatostatin analogues
AU6106801A (en) Trans-clitoral administration of therapy
WO2001062260A3 (en) Improvement of implantation rate
AU2002257572A1 (en) Use of carnitine for increasing testosteron
AU2002300032A1 (en) Combination preparation for the therapy of immunological diseases

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP